• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉美儿童川崎病的临床特征和结局:来自 REKAMLATINA 网络的多中心观察性研究。

Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network.

机构信息

University of California, San Diego / Rady Children's Hospital San Diego, San Diego, CA.

Department of Biology, San Francisco State University, San Francisco, CA.

出版信息

J Pediatr. 2023 Dec;263:113346. doi: 10.1016/j.jpeds.2023.02.001. Epub 2023 Feb 11.

DOI:10.1016/j.jpeds.2023.02.001
PMID:36775190
Abstract

OBJECTIVES

To describe the clinical presentation, management, and outcomes of Kawasaki disease (KD) in Latin America and to evaluate early prognostic indicators of coronary artery aneurysm (CAA).

STUDY DESIGN

An observational KD registry-based study was conducted in 64 participating pediatric centers across 19 Latin American countries retrospectively between January 1, 2009, and December 31, 2013, and prospectively from June 1, 2014, to May 31, 2017. Demographic and initial clinical and laboratory data were collected. Logistic regression incorporating clinical factors and maximum coronary artery z-score at initial presentation (between 10 days before and 5 days after intravenous immunoglobulin [IVIG]) was used to develop a prognostic model for CAA during follow-up (>5 days after IVIG).

RESULTS

Of 1853 patients with KD, delayed admission (>10 days after fever onset) occurred in 16%, 25% had incomplete KD, and 11% were resistant to IVIG. Among 671 subjects with reported coronary artery z-score during follow-up (median: 79 days; IQR: 36, 186), 21% had CAA, including 4% with giant aneurysms. A simple prognostic model utilizing only a maximum coronary artery z-score ≥2.5 at initial presentation was optimal to predict CAA during follow-up (area under the curve: 0.84; 95% CI: 0.80, 0.88).

CONCLUSION

From our Latin American population, coronary artery z-score ≥2.5 at initial presentation was the most important prognostic factor preceding CAA during follow-up. These results highlight the importance of early echocardiography during the initial presentation of KD.

摘要

目的

描述拉丁美洲川崎病(KD)的临床特征、治疗方法和转归,并评估冠状动脉瘤(CAA)的早期预后指标。

研究设计

本研究为观察性 KD 登记研究,2009 年 1 月 1 日至 2013 年 12 月 31 日在拉丁美洲 19 个国家的 64 家儿科中心进行回顾性分析,2014 年 6 月 1 日至 2017 年 5 月 31 日进行前瞻性分析。收集人口统计学、初始临床和实验室数据。采用包含临床因素和初始表现时(静脉用免疫球蛋白[IVIG]前 10 天至后 5 天)最大冠状动脉 z 评分的 Logistic 回归来建立随访期间(IVIG 后>5 天)CAA 的预后模型。

结果

在 1853 例 KD 患者中,延迟就诊(发热后>10 天)占 16%,不完全 KD 占 25%,IVIG 耐药占 11%。在 671 例有随访期间冠状动脉 z 评分报告的患者中(中位数:79 天;IQR:36,186),21%有 CAA,其中 4%为巨大动脉瘤。仅使用初始表现时最大冠状动脉 z 评分≥2.5 的简单预后模型预测随访期间 CAA 的效果最佳(曲线下面积:0.84;95%CI:0.80,0.88)。

结论

在我们的拉丁美洲人群中,初始表现时冠状动脉 z 评分≥2.5 是预测随访期间 CAA 的最重要的预后因素。这些结果突出了在 KD 初始表现时早期行超声心动图检查的重要性。

相似文献

1
Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network.拉美儿童川崎病的临床特征和结局:来自 REKAMLATINA 网络的多中心观察性研究。
J Pediatr. 2023 Dec;263:113346. doi: 10.1016/j.jpeds.2023.02.001. Epub 2023 Feb 11.
2
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.川崎病冠状动脉瘤:美国人群中进展性疾病和不良心脏事件的危险因素。
J Am Heart Assoc. 2016 Sep 15;5(9):e003289. doi: 10.1161/JAHA.116.003289.
3
Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.土耳其儿童川崎病:单中心经验,重点关注静脉注射免疫球蛋白抵抗和巨大冠状动脉瘤
Turk J Pediatr. 2019;61(5):648-656. doi: 10.24953/turkjped.2019.05.002.
4
Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.川崎病患者冠状动脉瘤严重程度与后期冠状动脉事件风险的相关性研究。
JAMA Pediatr. 2018 May 7;172(5):e180030. doi: 10.1001/jamapediatrics.2018.0030.
5
Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.川崎病伴低丙种球蛋白血症静脉用免疫球蛋白抵抗风险的冠状动脉瘤危险因素:POST-RAISE 分析。
J Pediatr. 2022 Jan;240:158-163.e4. doi: 10.1016/j.jpeds.2021.08.065. Epub 2021 Aug 27.
6
A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.一项关于川崎病合并冠状动脉瘤患者的注册研究(KIDCAR):启动三年后的多中心前瞻性注册研究报告
Eur J Pediatr. 2023 Feb;182(2):633-640. doi: 10.1007/s00431-022-04719-x. Epub 2022 Nov 25.
7
Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.冠状动脉瘤风险因素:中国低丙种球蛋白血症型川崎病患儿的回顾性队列研究
Cardiology. 2023;148(5):457-468. doi: 10.1159/000530708. Epub 2023 May 23.
8
The Harada score in the US population of children with Kawasaki disease.美国川崎病患儿群体中的原田评分。
Hosp Pediatr. 2014 Jul;4(4):233-8. doi: 10.1542/hpeds.2014-0008.
9
[Kawasaki disease in children--9 years experience].[儿童川崎病——9年经验]
Med Wieku Rozwoj. 2005 Apr-Jun;9(2):179-93.
10
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.多中心、随机、开放标签、盲终点评估的皮质类固醇加静脉注射免疫球蛋白(IVIG)和阿司匹林与 IVIG 和阿司匹林预防川崎病(KD)冠状动脉瘤(CAA)的试验:KD CAA 预防(KD-CAAP)试验方案。
Trials. 2023 Jan 26;24(1):60. doi: 10.1186/s13063-022-07051-9.

引用本文的文献

1
Early Diagnosis and Cardiac Complications of Kawasaki Disease in a Resource-Limited Regional Hospital.资源有限地区医院中川崎病的早期诊断及心脏并发症
Cureus. 2025 Apr 13;17(4):e82205. doi: 10.7759/cureus.82205. eCollection 2025 Apr.
2
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
3
Impact of social determinants of health on the outcomes of Latin American children with Multisystem Inflammatory Syndrome (MIS-C).
健康的社会决定因素对患有多系统炎症综合征(MIS-C)的拉丁美洲儿童结局的影响。
Pediatr Pulmonol. 2025 Jan;60(1):e27313. doi: 10.1002/ppul.27313. Epub 2024 Dec 26.
4
A prediction model for coronary artery abnormalities in children with Kawasaki disease older than 5 years.5岁以上川崎病患儿冠状动脉异常的预测模型。
J Pediatr (Rio J). 2024 May-Jun;100(3):318-326. doi: 10.1016/j.jped.2023.12.002. Epub 2024 Jan 2.
5
Kawasaki Disease: A Never-ending Story?川崎病:一个没有尽头的故事?
Eur Cardiol. 2023 Jul 27;18:e47. doi: 10.15420/ecr.2023.15. eCollection 2023.